
Tempus AI, a healthcare technology company, made its debut on the Nasdaq stock exchange under the ticker symbol $TEM. The company, which is backed by Google and Revolution Growth, opened trading at $40 per share, up from its initial pricing of $37, and saw its stock price rise to over $42. Tempus AI's IPO is expected to raise about $400 million. The company, founded by Eric Lefkofsky, focuses on data-driven precision medicine and has deployed 60 AI algorithms clinically. By the end of its first trading day, Tempus AI's stock closed up 9%, after rising by as much as 15% during its Nasdaq stock market debut.







AI is now predicting future events with astonishing accuracy! 🤖 New advancements in AI automation are setting the stage for revolutionary changes in industries. How will this impact your field? #AI #FutureInnovation
Got $5,000? Invest in AI with these top tech stocks for long-term growth! 📈💡 #AI #TechInvesting at its finest. What's your next move? https://t.co/zP8IUHbxm6
AI stocks are heating up this May! 🔥 Analysts spotlight NVIDIA and a rising AI star, both showing strong financials and growth potential. Are these the next big winners in your portfolio? 💹 #AIStocks #Investing